IL17A and asthma: Moreover, NET dismantling with DNase I or IL-17A blocking on NET structures markedly reduces the fibrotic potential of HELFs, suggesting that neutrophils/NETs can be considered both markers of disease severity and active contributors to asthma pathogenesis.